Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Concordia International Corp. stock logo
CXR
Concordia International
C$0.00
C$19.02
C$417.00
C$1.22BN/A4,054 shs73,541 shs
Mesabi Trust stock logo
MSB
Mesabi Trust
$24.89
+2.7%
$25.67
$15.93
$37.00
$326.61M0.5442,271 shs14,885 shs
NewMarket Corporation stock logo
NEU
NewMarket
$737.28
+2.4%
$648.18
$480.00
$737.28
$6.95B0.4251,996 shs116,709 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Concordia International Corp. stock logo
CXR
Concordia International
0.00%0.00%0.00%0.00%0.00%
Mesabi Trust stock logo
MSB
Mesabi Trust
+2.84%+6.04%-7.31%+1.11%+40.80%
NewMarket Corporation stock logo
NEU
NewMarket
+2.40%+8.21%+15.15%+35.43%+41.92%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Concordia International Corp. stock logo
CXR
Concordia International
N/AN/AN/AN/AN/AN/AN/AN/A
Mesabi Trust stock logo
MSB
Mesabi Trust
0.6555 of 5 stars
0.02.02.50.00.00.01.3
NewMarket Corporation stock logo
NEU
NewMarket
2.47 of 5 stars
0.03.02.50.02.73.31.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Concordia International Corp. stock logo
CXR
Concordia International
0.00
N/AN/AN/A
Mesabi Trust stock logo
MSB
Mesabi Trust
0.00
N/AN/AN/A
NewMarket Corporation stock logo
NEU
NewMarket
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Concordia International Corp. stock logo
CXR
Concordia International
C$569.62M0.00N/A5.85C$6.08 per share0.00
Mesabi Trust stock logo
MSB
Mesabi Trust
$23.79M13.73$7.30 per share3.41$1.49 per share16.71
NewMarket Corporation stock logo
NEU
NewMarket
$2.79B2.50$61.80 per share11.93$152.33 per share4.84
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Concordia International Corp. stock logo
CXR
Concordia International
N/AC$351.680.07N/AN/AN/AN/AN/AN/A
Mesabi Trust stock logo
MSB
Mesabi Trust
$93.27M$7.123.50N/A96.23%233.00%145.93%9/3/2025 (Estimated)
NewMarket Corporation stock logo
NEU
NewMarket
$462.41M$50.2414.68N/A17.22%34.45%15.16%8/4/2025 (Estimated)

Latest PYC, MSB, NEU, and CXR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/12/2025Q1 2026
Mesabi Trust stock logo
MSB
Mesabi Trust
N/A$0.28N/A$0.28N/A$4.74 million
4/24/2025Q4 2025
Mesabi Trust stock logo
MSB
Mesabi Trust
N/A$0.46N/A$0.46N/A$6.85 million
4/23/2025Q1 2025
NewMarket Corporation stock logo
NEU
NewMarket
N/A$13.26N/A$13.26N/A$700.95 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Concordia International Corp. stock logo
CXR
Concordia International
N/AN/AN/AN/AN/A
Mesabi Trust stock logo
MSB
Mesabi Trust
$2.249.00%N/A31.46%N/A
NewMarket Corporation stock logo
NEU
NewMarket
$11.001.49%N/A21.89%7 Years

Latest PYC, MSB, NEU, and CXR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2025
NewMarket Corporation stock logo
NEU
NewMarket
quarterly$2.751.81%6/16/20256/16/20257/1/2025
4/23/2025
Mesabi Trust stock logo
MSB
Mesabi Trust
$0.568.05%4/30/20255/1/20255/20/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Concordia International Corp. stock logo
CXR
Concordia International
457.02
2.10
1.66
Mesabi Trust stock logo
MSB
Mesabi Trust
N/A
3.51
3.51
NewMarket Corporation stock logo
NEU
NewMarket
0.65
2.84
1.60

Institutional Ownership

CompanyInstitutional Ownership
Concordia International Corp. stock logo
CXR
Concordia International
N/A
Mesabi Trust stock logo
MSB
Mesabi Trust
N/A
NewMarket Corporation stock logo
NEU
NewMarket
61.09%

Insider Ownership

CompanyInsider Ownership
Concordia International Corp. stock logo
CXR
Concordia International
N/A
Mesabi Trust stock logo
MSB
Mesabi Trust
0.26%
NewMarket Corporation stock logo
NEU
NewMarket
19.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Concordia International Corp. stock logo
CXR
Concordia International
22,50048.91 millionN/ANot Optionable
Mesabi Trust stock logo
MSB
Mesabi Trust
N/A13.12 million13.09 millionOptionable
NewMarket Corporation stock logo
NEU
NewMarket
2,0609.43 million7.63 millionOptionable

Recent News About These Companies

Does NewMarket (NYSE:NEU) Deserve A Spot On Your Watchlist?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Concordia International stock logo

Concordia International TSE:CXR

Concordia International Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates through two segments, Concordia International and Concordia North America. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies. This segment's products include Macrobid/Macrodantin to treat bladder infections, such as cystitis and urinary tract infections; Tetroxin drug for severe hypothyroid states; Eltroxin, levothyroxine sodium that treats patients with an underactive thyroid gland; and Fucithalmic, a topical gel treatment for patients suffering with a bacterial infection of the surface lining of the front of the eye. The Concordia North America segment provides Donnatalm, which is used as adjunctive therapy for irritable bowel syndrome; Zonegran, an anti-seizure drug indicated for adjunctive therapy in the treatment of partial seizures in adults with epilepsy; and Plaquenil and Plaquenil AG to treat rheumatoid arthritis and manage the complications of lupus, as well as suppress acute attacks from certain strains of malaria. This segment also offers photodynamic therapy with Photofrin for the treatment of certain forms of cancer that combines a photosensitizing agent with a specific type of laser that emits an exact wavelength of light and power to target cancer cells. The company sells its products through direct sales and local partnerships. The company was formerly known as Concordia Healthcare Corp. and changed its name to Concordia International Corp. in 2016. Concordia International Corp. is headquartered in Oakville, Canada.

Mesabi Trust stock logo

Mesabi Trust NYSE:MSB

$24.89 +0.64 (+2.66%)
As of 07/3/2025 03:45 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Mesabi Trust, a royalty trust, engages in iron ore mining business in the United States. Mesabi Trust was founded in 1961 and is based in New York, New York.

NewMarket stock logo

NewMarket NYSE:NEU

$737.28 +17.18 (+2.39%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$736.18 -1.10 (-0.15%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NewMarket Corporation, through its subsidiaries, primarily engages in the manufacture and sale of petroleum additives. The company offers lubricant additives for use in various vehicle and industrial applications, including engine oils, transmission fluids, off-road powertrain and hydraulic systems, gear oils, hydraulic oils, turbine oils, and other applications where metal-to-metal moving parts are utilized; engine oil additives designed for passenger cars, motorcycles, on and off-road heavy duty commercial equipment, locomotives, and engines in ocean-going vessels; driveline additives designed for products, such as transmission fluids, axle fluids, and off-road powertrain fluids; and industrial additives designed for products for industrial applications consisting of hydraulic fluids, grease, industrial gear fluids, and industrial specialty applications, such as turbine oils. It also provides fuel additives that are used to enhance the oil refining process and the performance of gasoline, diesel, biofuels, and other fuels to industry, government, original equipment manufacturers, and individual customers. In addition, the company engages in the marketing of antiknock compounds, as well as contracted manufacturing and services activities; and owns and manages a real property in Virginia. It operates in North America, Latin America, Asia Pacific, Europe, the Middle East, Africa, and India. NewMarket Corporation was founded in 1887 and is headquartered in Richmond, Virginia.